Welcome to our dedicated page for Siriuspoint SEC filings (Ticker: SSPFF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Siriuspoint's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Siriuspoint's regulatory disclosures and financial reporting.
SiriusPoint Ltd has had its 8.00% Resettable Fixed Rate Preference Shares, Series B removed from listing and registration on the New York Stock Exchange LLC. The Exchange states it complied with Rule 17 CFR 240.12d2-2 and that the issuer complied with the Exchange's withdrawal requirements.
SiriusPoint Ltd has had its 8.00% Resettable Fixed Rate Preference Shares, Series B removed from listing and registration on the New York Stock Exchange LLC. The Exchange states it complied with Rule 17 CFR 240.12d2-2 and that the issuer complied with the Exchange's withdrawal requirements.
SiriusPoint Ltd. reports on its 2025 performance as a global specialty insurance and reinsurance underwriter headquartered in Bermuda. The company had common shareholders’ equity of $2.3 billion, total capital of $3.2 billion and total assets of $12.6 billion as of December 31, 2025.
Core underwriting income reached $214.3 million with a combined ratio of 91.7%, slightly better than 2024’s $200.0 million and 91.0%. Gross written premium increased to $3,705.6 million from $3,244.6 million, while net earned premium rose to $2,593.8 million. The business mix continued shifting toward Accident & Health, Casualty and Other Specialties.
Investment results were strong at $271.9 million, driven by $274.8 million of net investment income and minimal net realized and unrealized losses. Service fee income from consolidated MGAs totaled $41.8 million, and the sale of Armada generated a gain of $222.4 million. The group maintains A-/A3 financial strength ratings with positive or stable outlooks.
SiriusPoint Ltd. reports on its 2025 performance as a global specialty insurance and reinsurance underwriter headquartered in Bermuda. The company had common shareholders’ equity of $2.3 billion, total capital of $3.2 billion and total assets of $12.6 billion as of December 31, 2025.
Core underwriting income reached $214.3 million with a combined ratio of 91.7%, slightly better than 2024’s $200.0 million and 91.0%. Gross written premium increased to $3,705.6 million from $3,244.6 million, while net earned premium rose to $2,593.8 million. The business mix continued shifting toward Accident & Health, Casualty and Other Specialties.
Investment results were strong at $271.9 million, driven by $274.8 million of net investment income and minimal net realized and unrealized losses. Service fee income from consolidated MGAs totaled $41.8 million, and the sale of Armada generated a gain of $222.4 million. The group maintains A-/A3 financial strength ratings with positive or stable outlooks.
SiriusPoint Ltd. reported very strong fourth-quarter and full-year 2025 results, highlighting profitable growth and capital returns. Net income available to common shareholders reached $240 million in Q4, or $1.97 per diluted share, with operating earnings per share of $0.70. Annual net income was $444 million, or $3.64 per diluted share, and operating earnings per share rose 49% to $2.55. The company delivered an annualized return on equity of 44.9% in Q4 and 22.1% for the year, with operating ROE of 16.2%. Gross written premiums grew 16% in 2025 and the Core combined ratio was 91.7%, indicating solid underwriting profitability.
Book value per common share increased to $19.40, while book value per diluted share excluding AOCI rose 23.6% to $18.10. SiriusPoint announced it will redeem all Series B preference shares, expecting its leverage ratio to fall to about 23%, and plans to repurchase $100 million of common shares over the next 12 months. The balance sheet remained strong with a year-end BSCR estimate of 247%. Strategic actions included selling a 49% stake in Arcadian for $140.4 million (with an expected pre-tax gain of about $25 million in the first quarter of 2026) and agreements to acquire Assist America for approximately $42.5 million and the World Nomads travel insurance business to expand medical and travel assistance capabilities.
SiriusPoint Ltd. reported very strong fourth-quarter and full-year 2025 results, highlighting profitable growth and capital returns. Net income available to common shareholders reached $240 million in Q4, or $1.97 per diluted share, with operating earnings per share of $0.70. Annual net income was $444 million, or $3.64 per diluted share, and operating earnings per share rose 49% to $2.55. The company delivered an annualized return on equity of 44.9% in Q4 and 22.1% for the year, with operating ROE of 16.2%. Gross written premiums grew 16% in 2025 and the Core combined ratio was 91.7%, indicating solid underwriting profitability.
Book value per common share increased to $19.40, while book value per diluted share excluding AOCI rose 23.6% to $18.10. SiriusPoint announced it will redeem all Series B preference shares, expecting its leverage ratio to fall to about 23%, and plans to repurchase $100 million of common shares over the next 12 months. The balance sheet remained strong with a year-end BSCR estimate of 247%. Strategic actions included selling a 49% stake in Arcadian for $140.4 million (with an expected pre-tax gain of about $25 million in the first quarter of 2026) and agreements to acquire Assist America for approximately $42.5 million and the World Nomads travel insurance business to expand medical and travel assistance capabilities.
SiriusPoint Ltd. announced that its wholly owned subsidiary International Medical Group (IMG) has signed a definitive agreement to acquire the World Nomads travel insurance business from nib Group. World Nomads generates approximately $40 million of gross written premium and is a global travel insurance and lifestyle brand.
The deal is expected to significantly expand IMG’s travel insurance distribution, adding a broad base of independent, lifestyle, and adventure travelers and extending its reach to Australia, Brazil, and Canada. Together with IMG’s recent acquisition of Assist America, which produces around $20 million in annual assistance revenues, the combination creates an integrated travel insurance and assistance platform.
The company states that both the World Nomads and Assist America acquisitions are accretive to return on equity and earnings per share. An initial closing for the majority of World Nomads is targeted for the second or third quarter of 2026, with final closing in the second half of 2027, in each case subject to regulatory approvals and other customary conditions.
SiriusPoint Ltd. announced that its wholly owned subsidiary International Medical Group (IMG) has signed a definitive agreement to acquire the World Nomads travel insurance business from nib Group. World Nomads generates approximately $40 million of gross written premium and is a global travel insurance and lifestyle brand.
The deal is expected to significantly expand IMG’s travel insurance distribution, adding a broad base of independent, lifestyle, and adventure travelers and extending its reach to Australia, Brazil, and Canada. Together with IMG’s recent acquisition of Assist America, which produces around $20 million in annual assistance revenues, the combination creates an integrated travel insurance and assistance platform.
The company states that both the World Nomads and Assist America acquisitions are accretive to return on equity and earnings per share. An initial closing for the majority of World Nomads is targeted for the second or third quarter of 2026, with final closing in the second half of 2027, in each case subject to regulatory approvals and other customary conditions.
Donald Smith & Co., Inc., a Delaware investment adviser, filed a Schedule 13G reporting beneficial ownership of 8,428,966 SiriusPoint Ltd common shares, representing about 7.2% of the class. The firm has sole voting power over most of these shares and holds them for advisory clients.
The filing states the securities were acquired and are held in the ordinary course of business, not to change or influence control of SiriusPoint. No single underlying client or other person is reported to own more than five percent of SiriusPoint’s outstanding common stock.
Donald Smith & Co., Inc., a Delaware investment adviser, filed a Schedule 13G reporting beneficial ownership of 8,428,966 SiriusPoint Ltd common shares, representing about 7.2% of the class. The firm has sole voting power over most of these shares and holds them for advisory clients.
The filing states the securities were acquired and are held in the ordinary course of business, not to change or influence control of SiriusPoint. No single underlying client or other person is reported to own more than five percent of SiriusPoint’s outstanding common stock.
SiriusPoint Ltd. reports that a subsidiary has completed the previously announced sale of its entire equity stake in Arcadian Holdings Limited to Comet Bidco Limited, an acquisition vehicle of funds affiliated with Lee Equity Partners. Under the Share Purchase Agreement dated October 3, 2025, SiriusPoint Bermuda Insurance Company Ltd., as seller, received cash consideration of $140 million, subject to customary post-closing adjustments. The transaction closed after all customary closing conditions were met, including required regulatory approvals.
SiriusPoint Ltd. reports that a subsidiary has completed the previously announced sale of its entire equity stake in Arcadian Holdings Limited to Comet Bidco Limited, an acquisition vehicle of funds affiliated with Lee Equity Partners. Under the Share Purchase Agreement dated October 3, 2025, SiriusPoint Bermuda Insurance Company Ltd., as seller, received cash consideration of $140 million, subject to customary post-closing adjustments. The transaction closed after all customary closing conditions were met, including required regulatory approvals.
SiriusPoint Ltd. has announced the full redemption of all 8,000,000 of its 8.00% Resettable Fixed Rate Preferred Shares, Series B. The redemption will occur on February 26, 2026, retiring this entire preferred share series.
The company also stated its intent to delist and deregister the Series B Preference Shares from the New York Stock Exchange and under U.S. securities laws. These steps consolidate its capital structure by removing this listed preferred security from public trading.
SiriusPoint Ltd’s chief executive officer and director Scott Egan reported an internal transfer of 545,083 common shares of SiriusPoint on 12/19/2025. The shares moved from his direct ownership to indirect ownership through Egan Family Investment Ltd., a UK family investment company, for estate planning purposes, and the filing states that no consideration was paid for the transfer.
After the transactions, Egan directly owns 239,083 common shares, and indirectly owns 545,083 common shares through Egan Family Investment Ltd. The filing notes that these holdings include restricted shares.
SiriusPoint Ltd’s chief executive officer and director Scott Egan reported an internal transfer of 545,083 common shares of SiriusPoint on 12/19/2025. The shares moved from his direct ownership to indirect ownership through Egan Family Investment Ltd., a UK family investment company, for estate planning purposes, and the filing states that no consideration was paid for the transfer.
After the transactions, Egan directly owns 239,083 common shares, and indirectly owns 545,083 common shares through Egan Family Investment Ltd. The filing notes that these holdings include restricted shares.
A shareholder of the SPNT issuer has filed a Rule 144 notice to sell 37,311 shares of common stock. The sale is planned to occur around 12/12/2025 on the NYSE through J.P. Morgan Securities LLC. Based on the filing, the aggregate market value of the shares to be sold is $831,289.08, compared with 116,814,640 shares of the same class outstanding. The shares were originally acquired on 12/31/2012 as a gift from Clare Loeb, who had acquired the shares earlier. By signing the notice, the seller represents that they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.
A shareholder of the SPNT issuer has filed a Rule 144 notice to sell 37,311 shares of common stock. The sale is planned to occur around 12/12/2025 on the NYSE through J.P. Morgan Securities LLC. Based on the filing, the aggregate market value of the shares to be sold is $831,289.08, compared with 116,814,640 shares of the same class outstanding. The shares were originally acquired on 12/31/2012 as a gift from Clare Loeb, who had acquired the shares earlier. By signing the notice, the seller represents that they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.
SiriusPoint Ltd. executive David E. Govrin, Group President, reported a share transaction involving company common shares. On 11/30/2025, 52,800 common shares were withheld at a price of $0 under transaction code "F", which indicates shares were withheld to cover current tax liabilities tied to the vesting of restricted shares. Following this transaction, he beneficially owned 517,975 common shares, which include restricted shares. The reported holdings were also adjusted to correct a prior overstatement by 6,570 shares.
SiriusPoint Ltd. executive David E. Govrin, Group President, reported a share transaction involving company common shares. On 11/30/2025, 52,800 common shares were withheld at a price of $0 under transaction code "F", which indicates shares were withheld to cover current tax liabilities tied to the vesting of restricted shares. Following this transaction, he beneficially owned 517,975 common shares, which include restricted shares. The reported holdings were also adjusted to correct a prior overstatement by 6,570 shares.